BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Allergy to pollen
,
Pancreas
,
Nosology
,
PPARA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Hyperlipoproteinemia type III
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Congenital disorder
Explore Curated Studies Results
Literature
Most Relevant Literature
Multi-omics Analyses Reveal Function of Apolipoprotein E in Alternative Splicing and Tumor Immune Mi…
Association between serum apolipoprotein E and cognitive function in Chinese patients with temporal …
Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration.
Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremi…
Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoprotei…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Type III Dysbetalipoproteinemia
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the …
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Diso…
Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Ca…
Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diag…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ